Clinical Safety and Efficacy of Ablation for Atrial Fibrillation Patients With a History of Stroke

To evaluate the clinical safety and efficacy of radiofrequency catheter ablation for atrial fibrillation patients with a history of stroke. A total of 116 symptomatic, drug-refractory AF patients with a history of stroke, and 1:2 matched patients without a history of stroke were enrolled. Of these,...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in cardiovascular medicine Vol. 8; p. 630090
Main Authors Song, Zi-Liang, Wu, Shao-Hui, Zhang, Dao-Liang, Jiang, Wei-Feng, Qin, Mu, Liu, Xu
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 10.03.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To evaluate the clinical safety and efficacy of radiofrequency catheter ablation for atrial fibrillation patients with a history of stroke. A total of 116 symptomatic, drug-refractory AF patients with a history of stroke, and 1:2 matched patients without a history of stroke were enrolled. Of these, 28 cases occurred stroke within 3 months (Group 1), 88 cases with stroke history longer than 3 months (Group 2), and 232 cases without stroke (Group 3). PVI was performed in all patients, extended to ablation of linear lesions ablation. The periprocedural stroke rates and other procedure-related in-hospital complications did not differ significantly among the three groups. The maintenance rate of SR after the procedure showed no significant difference ( = 0.333), 52.7, 66.4, and 70.7% in Group 1, 2, and 3, respectively. Furthermore, the comparison between a history of stroke and those without it were also shown no significant difference ( = 0.351). Radiofrequency ablation for AF patients occurred stroke, even within 3 months is safe and effective, without higher periprocedural complication rate and recurrence rate.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article was submitted to Cardiac Rhythmology, a section of the journal Frontiers in Cardiovascular Medicine
These authors have contributed equally to this work
Reviewed by: Osmar Antonio Centurion, National University of Asunción, Paraguay; Martin Ibarrola, Independent Researcher, Bella Vista, Argentina
Edited by: Shimon Rosenheck, Hebrew University of Jerusalem, Israel
ISSN:2297-055X
2297-055X
DOI:10.3389/fcvm.2021.630090